PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23139858-6	2012	This phenotypic change was completely reversed by p53 reactivation via treatment with proteasome inhibitor MG132 or co-knockdown of E3 ligase HDM2 and partially suppressed by ATP treatment.	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	107-112	tumor protein p53	Homo sapiens	50-53